Inhibition of chronic rejection of aortic allografts by dietary glycine

Transplantation

Volumn 69, Issue 5, 2000, Pages 773-780

  Yin, Ming ^a   Rusyn, Ivan ^a   Schoonhoven, Robert ^b   Graves, Lee M ^a   Rusyn, Elena V ^a   Li, Xiangli ^a   Li, Fengling ^a   Cox, Adrienne D ^a   Harding, Tim W ^a   Bunzendahl, Hartwig ^b   Swenberg, James A ^b   Thurman, Ronald G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GRAFT REJECTION; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RISK FACTOR; SMOOTH MUSCLE FIBER;

EID: 0034654113     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00017     Document Type: Article

References (48)

1. Paul LC. Chronic rejection of organ allografts: magnitude of the problem. Transplant Proc 1993; 25: 2024.
2. Chomette G, Auriol M, Cabrol C. Chronic rejection in human heart transplantation. J Heart Lung Transplant 1998; 7: 292.
3. Hayry P, Isoniemi H, Yilmaz S, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33.
4. Foegh ML. Chronic rejection-graft arteriosclerosis. Transplant Proc 1990; 22: 119.
5. Demetris AJ, Zerbe T, Banner B. Morphology of solid organ allograft arteriopathy: Identification of proliferating intimal cell populations. Transplant Proc 1989; 21: 3667.
6. Uys C, Rose A. Pathologic findings in long-term cardiac transplants. Arch Pathol Lab Med 1984; 108: 112.
7. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992; 3: 538.
8. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
9. Terasaki PI, Cecka JM, Gjertson DW, Hao Y, Takemoto S, Cohn M. A ten year prediction for kidney transplant survival. In: Terasaki PI, Cecka JM, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1992; 501.
10. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
11. Wilhelm MJ, Kusaka M, Pratschke J, Tilney NL. Chronic rejection: increasing evidence for the importance of allogen-independent factors. Transplant Proc 1998; 30: 2402.
12. Yilmaz S, Hayry P. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 1993; 56: 1153.
13. Zhong Z, Jones S, Thurman RG. Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Physiol 1996; 270: G332.
14. Ikejima K, Iimuro Y, Forman DT, Thurman RG. A diet containing glycine improves survival in endotoxin shock in the rat. Am J Physiol 1996; 271: G97.
15. Stachlewitz RF, Bunzendahl H, Thurman RG. Glycine is immunosuppresive in vitro: Prevention of agonist-induced increases in intracellular calcium and lymphocyte proliferation. Hepatology 1997; 26: 169A.
16. Zhong Z, Arteel GE, Connor H, et al. Cyclosporin A increases hypoxia and free radical production in the rat kidney: prevention by dietary glycine. Am J Physiol 1998; 275: F595.
17. Rose ML, Germolec DR, Arteel GE, Schoonhoven R, Thurman RG. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Chem Res Toxicol 1997; 10: 1198.
18. Yin M, Schoonhoven R, Swenberg JA, Thurman RG. Dietary glycine attenuates chronic rejection of rat aortic allografts. Abstracts of Transplantation Society, XVII World Congress, 1998; 53.
19. Reeves PG. Component of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997; 127 (5 Suppl): 838S.
20. Li F, Yin M, van Dam JG, Grauls G, Rozing J, Bruhheman CA. Cytomegalovirus infection enhances the neointima formation in rat aortic allografts: The effect of major histo-compatibility complex class I and class II antigen differences. Transplantation 1998; 65: 1298.
21. Ohmori S, Ikeda M, Watanabe Y, Hirota K. A simple and specific determination of glycine in biological samples. Anal Biochem 1978; 90: 662.
22. Bruning JH, Persoon M, Lemstrom K, Stals FS, Clerq de E, Bruggeman CA. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by anti-viral therapy in the form of HPMPC. Transplant Int 1994; 7 (Suppl): S365.
23. Mennander A, Paavonen T, Hayry P. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated. Arteriosc Thromb 1993; 13: 1019.
24. Mennander A, Tiisala S, Paavonen T, Halttunen J, Hayry P. Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis. Transplant Int 1991; 4: 173.
25. Brinson AE, Harding T, Diliberto PA, et al. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. J Biol Chem 1998; 273: 1711.
26. Palmer D, Tsoi K, Maurice DH. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors. Circ Res 1998; 82: 852.
27. Geraghty JG, Stoltenberg RL, Sollinger HW, Hullett DA. Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection. Transplantation 1996; 62: 502.
28. Rosse RB, Theut SK, Banay-Schwartz M, et al. Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: An open-label, pilot study. Clin Neuropharmacol 1989; 12: 416.
29. Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991; 138: 791.
30. Hayry P, Mennander A, Yilmaz S, et al. Towards understanding the pathophysiology of chronic rejection. Clin Invest 1992; 70: 780.
31. Land W. Prologue. Transplant Proc 1998; 30: 4210.
32. Currin RT, Caldwell-Kenkel JC, Lichtman SN, et al. Protection by Carolina rinse solution, acidotic pH, and glycine against lethal reperfusion injury to sinusoidal endothelial cells of rat livers stored for transplantation. Transplantation 1996; 62: 1549.
33. Weinberg JM, Varani J, Johnson KJ, et al. Protection of human unbilical vein endothelial cells by glycine and structurally similar amino acids against calcium and hydrogen peroxide-induced lethal cell injury. Am J Pathol 1992; 140: 457.
34. Brasile L, Zerbe T, Rabin B, Clarke J, Abrams A, Cerilli J Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation 1985; 40: 672.
35. Jain P, Khanna NK, Godhwani JL. Modification of immune response by glycine in animals. Ind J Exp Biol 1989; 27: 292.
36. Cramer DV, Wu GD, Chapman FA, Cajulis E, Wang HK, Makowka L. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J Heart Lung Transplant 1992; 11: 458.
37. Russell ME, Wallace AF, Hancock WW, et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995; 59: 572.
38. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc 1987; 19: 19.
39. Hayry P. Chronic rejection: risk factors, regulation, and possible sites of theraputic intervention. Transplant Proc 1998; 30: 2407.
40. Aziz S, McDonald TO, Gohra H. Transplant arterial vasculopathy: Evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. J Heart Lung Transplant 1995; 14: S123.
41. Shimokado K, Raines EW, Madtes DK, Barrett TB, Benditt EP, Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985; 43: 277.
42. Pfeiffer CJ. The psychologic effects of restricted activity in the rats: stress effects of chronic restraint. Exp Med Surg 1967; 25: 201.
43. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493.
44. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 92: 1565.
45. Ikejima K, Qu W, Stachlewitz RF, Thurman RG. Kupffer cells contain a glycine-gated chloride channel. Am J Physiol 1997; 272: G1581.
46. Kuwajima M, Jacobsson J, Kagan E, Ramwell PW, Foegh ML. Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit. Transplantation 1991; 52: 759.
47. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Hayry P. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arteriosc Thromb 1991; 11: 671.
48. Karaki HOH, Hori M, Mitsui-Saito M, et al. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997; 49: 157.